Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
Alkermes stock last closed at $49.21, up 0.7% from the previous day, and has increased 69.69% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 1.63 percentage points. Alkermes stock is currently +95.55% from its 52-week low of $25.17, and -11.6% from its 52-week high of $55.67.
There are currently 167.76M shares of ALKS outstanding. The market capitalization of ALKS is $8.26B. In the last 24 hours, 1.04M ALKS shares were traded.
How to Buy Alkermes Stock
Not sure how to invest in Alkermes stock? Here's how.
Figure out where to buy Alkermes stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you determine where to buy Alkermes stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit money your investment account: Choose your method of payment and add your info.
Research Alkermes stock: The Alkermes ticker symbol is ALKS. Is Alkermes stock a good investment? Should you buy shares of ALKS? How do ALKS's underlying business fundamentals look? Do top analysts think Alkermes is a good buy? Why has ALKS's stock price moved recently? (Hint: Our stock market research tools can help you decide if ALKS is a good stock to buy).
Place your ALKS purchase: Decide if you will purchase ALKS shares at the current market price or use a limit order to purchase ALKS shares at a specific price.
Get notifications regarding your ALKS investment: Create a watchlist to key updates about your investment in Alkermes stock.
Step 1: Figure out where to buy Alkermes stock
You will need a brokerage account to access the NASDAQ market and buy ALKS stock.
A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world financial markets: From Technology to Utilities, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've picked your brokerage, it's time to fill out some personal info so you are able to invest in ALKS stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Alkermes stock
After you have chosen the best place to buy Alkermes stock, it's very important to evaluate their stock before you invest, so you actually wrap your head around the risk and opportunity.
Alkermes stock data
ALKS Price
$49.21
1w %
-0.55%
1y %
69.69%
5y %
60.55%
P/E
123.03x
P/B
4.56x
P/S
4.93x
PEG
2.1x
Revenue
$1.67B
Earnings
$66.12M
Fore. Rev. Growth
8.94%
Fore. Earn. Growth
58.68%
Market Cap
$8.26B
Next Earnings
N/A
Next Dividend
N/A
ALKS Due Diligence Checks
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis.
There are more short-term assets than short-term liabilities on the ALKS balance sheet.
Negative Health Checks:
ALKS's operating cash flow of $251.18M allows it to safely service it's debt of $1.57B.
There are more long-term liabilities than short-term assets on the ALKS balance sheet.
ALKS profit margin has gone down from 23.1% to 4% in the past year.
Total ALKS debt is higher than 5 years ago, relative to shareholder equity.
ALKS earnings of $156.41M is not enough to cover its interest payments.
ALKS has a relatively high debt to equity ratio of 1.43.
Do Wall Street analysts think it's a good time to buy Alkermes stock
Out of 11 sell side analysts who monitor ALKS, the consensus analyst rating on ALKS is a Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent ALKS Analyst Recommendations
Uy Ear, a top 14% analyst from Mizuho maintains ALKS with a buy rating and raises their ALKS price target from $53.00 to $65.00, on Jul 2, 2026.
Benjamin Burnett, a top 16% analyst from Wells Fargo maintains ALKS with a strong buy rating and raises their ALKS price target from $44.00 to $65.00, on Jun 29, 2026.
Jason Gerberry, a top 12% analyst from Bank of America downgrades ALKS to a sell rating and announces their ALKS price target of $38.00, on Jun 29, 2026.
Joseph Thome, a bottom 8% analyst from TD Cowen maintains ALKS with a strong buy rating and raises their ALKS price target from $42.00 to $50.00, on Jun 22, 2026.
Leonid Timashev, a top 3% analyst from RBC Capital maintains ALKS with a buy rating and raises their ALKS price target from $45.00 to $56.00, on Jun 9, 2026.
Last year, ALKS earnings were $66.12M. Over the past 3 year, ALKS's earnings have increased by -70.09% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 6.81%.
Last year, ALKS revenue was $1.67B. During the last 5 year, ALKS's revenue has increased by 8.68% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 9.35%.
No, Alkermes doesn't provide an income stream by paying out dividends.
ALKS Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your ALKS purchase
There are two primary options:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are mostly the best for newer investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at an exact dollar amount, use a limit order.
Press the Open button and your broker will place the order.
If you want more assistance buying stocks on eToro, watch the helpful video below:
As of Aug 25, 2026, it costs $49.21 to buy one share of Alkermes stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.203 shares of ALKS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.